Pleiotropic effects of statins: do they matter?

被引:68
作者
Gotto, AM
Farmer, JA
机构
[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1097/00041433-200108000-00004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Treatment with the 3-hydroxy-3-methylglutaryl coenyzme A reductase inhibitors (or statins) reduces the risk for cardiovascular events across a broad spectrum of patient profiles, as evidenced by both primary prevention and secondary prevention trials. Improved survival by way of reduced deaths from coronary heart disease was also reported with these agents, which are primarily indicated for substantial reduction in LDL-cholesterol levels. However, the statins are extremely complex drugs and exhibit a wide variety of vascular effects that may or may not be dependent on their lipid-modifying properties. These so-called pleiotropic effects include alterations of endothelial function, inflammation, coagulation, and plaque stability. The relative contribution of the nonlipid effects of statin therapy to the well-documented clinical benefits is currently under intense investigation. Curr Opin Lipidol 12:391-394, (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:391 / 394
页数:4
相关论文
共 31 条
[1]  
Bellosta S, 2000, DIABETES CARE, V23, pB72
[2]  
Cannon RO, 2000, CIRCULATION, V102, P820
[3]   Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women [J].
Chan, KA ;
Andrade, SE ;
Boles, M ;
Buist, DSM ;
Chase, GA ;
Donahue, JG ;
Goodman, MJ ;
Gurwitz, JH ;
LaCroix, AZ ;
Platt, R .
LANCET, 2000, 355 (9222) :2185-2188
[4]   Low-density lipoprotein-independent effects of statins [J].
Davignon, J ;
Laaksonen, R .
CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (06) :543-559
[5]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[6]   Molecular basis of Alzheimer's disease [J].
Drouet, B ;
Pinçon-Raymond, M ;
Chambaz, J ;
Pillot, T .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (05) :705-715
[7]   Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase [J].
Endres, M ;
Laufs, U ;
Huang, ZH ;
Nakamura, T ;
Huang, P ;
Moskowitz, MA ;
Liao, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8880-8885
[8]  
Fonarow GC, 2001, CIRCULATION, V103, P38
[9]   Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women [J].
Higashi, Y ;
Sanada, M ;
Sasaki, S ;
Nakagawa, K ;
Goto, C ;
Matsuura, H ;
Ohama, K ;
Chayama, K ;
Oshima, T .
HYPERTENSION, 2001, 37 (02) :651-657
[10]   Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].
Hulley, S ;
Grady, D ;
Bush, T ;
Furberg, C ;
Herrington, D ;
Riggs, B ;
Vittinghoff, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613